Compare · ASTH vs EXPO
ASTH vs EXPO
Side-by-side comparison of Astrana Health Inc. (ASTH) and Exponent Inc. (EXPO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ASTH and EXPO operate in Professional Services (Consumer Discretionary), so they compete in similar markets.
- EXPO is the larger of the two at $2.71B, about 1.2x ASTH ($2.21B).
- Over the past year, ASTH is up 64.2% and EXPO is down 22.1% - ASTH leads by 86.3 points.
- EXPO has been more active in the news (9 items in the past 4 weeks vs 8 for ASTH).
- ASTH has more recent analyst coverage (7 ratings vs 2 for EXPO).
- Company
- Astrana Health Inc.
- Exponent Inc.
- Price
- $41.22+4.21%
- $57.41+2.66%
- Market cap
- $2.21B
- $2.71B
- 1M return
- +10.33%
- +0.60%
- 1Y return
- +64.20%
- -22.06%
- Industry
- Professional Services
- Professional Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 8
- 9
- Recent ratings
- 7
- 2
Exponent Inc.
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Latest ASTH
- Director Schmidt David was granted 4,525 shares, increasing direct ownership by 14% to 36,019 units (SEC Form 4)
- Director Mazdyasni Matthew was granted 4,525 shares, increasing direct ownership by 13% to 39,288 units (SEC Form 4)
- Director Kitayama Mitchell W was granted 4,991 shares, increasing direct ownership by 18% to 32,837 units (SEC Form 4)
- Director Dong Linda was granted 4,525 shares, increasing direct ownership by 5% to 97,133 units (SEC Form 4)
- Director Dai, Weili was granted 4,525 shares, increasing direct ownership by 33% to 18,188 units (SEC Form 4)
- Director Chiang John was granted 4,525 shares, increasing direct ownership by 15% to 35,373 units (SEC Form 4)
- Astrana Health Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth
- Astrana Health upgraded by Barclays with a new price target
- COO and CFO Basho Chandan covered exercise/tax liability with 8,155 shares, decreasing direct ownership by 5% to 159,610 units (SEC Form 4) (tax withholding)
Latest EXPO
- President & CEO Corrigan Catherine exercised 5,605 shares at a strike of $26.95 and sold $235,303 worth of shares (4,119 units at $57.13), increasing direct ownership by 1% to 107,257 units (SEC Form 4)
- Exponent to Host Investor Day at Phoenix Test & Engineering Center
- Exponent Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Exponent to Participate in a Fireside Chat at the Wells Fargo 16th Annual Industrials & Materials Conference
- Director Lindstrom Carol converted options into 2,009 shares, increasing direct ownership by 27% to 9,405 units (SEC Form 4)
- Director Richardson Karen A converted options into 2,009 shares (SEC Form 4)
- Director Brown George H. converted options into 2,009 shares, increasing direct ownership by 23% to 10,730 units (SEC Form 4)
- Director Zumwalt Debra converted options into 2,009 shares, increasing direct ownership by 7% to 31,830 units (SEC Form 4)
- Director Johnston Paul R converted options into 2,009 shares, increasing direct ownership by 3% to 62,940 units (SEC Form 4)
- Group Vice President James Bradley A sold $114,930 worth of shares (2,000 units at $57.47), decreasing direct ownership by 64% to 1,105 units (SEC Form 4)